Cargando…
Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study
Herein we have made a comprehensive analysis of inhibitory efficacy of 16 RNA virus drugs against RdRp, Mpro and PLpro proteins of SARS-CoV-2. Analysis of docked conformation revealed that Baloxavir marboxil (BMX) corresponds to the highest binding energy. Analysis of residue confirmed that BMX stro...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909904/ https://www.ncbi.nlm.nih.gov/pubmed/33678903 http://dx.doi.org/10.1016/j.molstruc.2021.130152 |
_version_ | 1783656022990127104 |
---|---|
author | Mandal, Manab Chowdhury, Swapan Kumar Khan, Abdul Ashik Baildya, Nabajyoti Dutta, Tanmoy Misra, Debabrata Ghosh, Narendra Nath |
author_facet | Mandal, Manab Chowdhury, Swapan Kumar Khan, Abdul Ashik Baildya, Nabajyoti Dutta, Tanmoy Misra, Debabrata Ghosh, Narendra Nath |
author_sort | Mandal, Manab |
collection | PubMed |
description | Herein we have made a comprehensive analysis of inhibitory efficacy of 16 RNA virus drugs against RdRp, Mpro and PLpro proteins of SARS-CoV-2. Analysis of docked conformation revealed that Baloxavir marboxil (BMX) corresponds to the highest binding energy. Analysis of residue confirmed that BMX strongly interact with these three proteins involving H-bonding, ionic as well as hydrophobic interactions. Molecular dynamics simulation and analysis of parameters like RMSD, RMSF, binding energy confirmed noticeable conformational alternation with these proteins with makeable effect on RdRp. The potentially inhibitory action of BMX against these three proteins suggests the inhibition of overall transcription process of SARS-CoV-2. These observation along with the recently observed inhibitory action of BMX on influenza with clinically proven no side effects emphasizes to uncover the role of BMX by in-vitro and in-vivo analysis. |
format | Online Article Text |
id | pubmed-7909904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79099042021-03-01 Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study Mandal, Manab Chowdhury, Swapan Kumar Khan, Abdul Ashik Baildya, Nabajyoti Dutta, Tanmoy Misra, Debabrata Ghosh, Narendra Nath J Mol Struct Article Herein we have made a comprehensive analysis of inhibitory efficacy of 16 RNA virus drugs against RdRp, Mpro and PLpro proteins of SARS-CoV-2. Analysis of docked conformation revealed that Baloxavir marboxil (BMX) corresponds to the highest binding energy. Analysis of residue confirmed that BMX strongly interact with these three proteins involving H-bonding, ionic as well as hydrophobic interactions. Molecular dynamics simulation and analysis of parameters like RMSD, RMSF, binding energy confirmed noticeable conformational alternation with these proteins with makeable effect on RdRp. The potentially inhibitory action of BMX against these three proteins suggests the inhibition of overall transcription process of SARS-CoV-2. These observation along with the recently observed inhibitory action of BMX on influenza with clinically proven no side effects emphasizes to uncover the role of BMX by in-vitro and in-vivo analysis. Elsevier B.V. 2021-06-15 2021-02-26 /pmc/articles/PMC7909904/ /pubmed/33678903 http://dx.doi.org/10.1016/j.molstruc.2021.130152 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mandal, Manab Chowdhury, Swapan Kumar Khan, Abdul Ashik Baildya, Nabajyoti Dutta, Tanmoy Misra, Debabrata Ghosh, Narendra Nath Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study |
title | Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study |
title_full | Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study |
title_fullStr | Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study |
title_full_unstemmed | Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study |
title_short | Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study |
title_sort | inhibitory efficacy of rna virus drugs against sars-cov-2 proteins: an extensive study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909904/ https://www.ncbi.nlm.nih.gov/pubmed/33678903 http://dx.doi.org/10.1016/j.molstruc.2021.130152 |
work_keys_str_mv | AT mandalmanab inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy AT chowdhuryswapankumar inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy AT khanabdulashik inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy AT baildyanabajyoti inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy AT duttatanmoy inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy AT misradebabrata inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy AT ghoshnarendranath inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy |